Company Profile
Embracing Future Holdings Limited, a precision medicine medical technology company focuses on developing a portfolio of diagnostic solutions in Singapore, China, and Hong Kong.
Its business is organized into Cancer, Infectious Diseases, E-Sports, and Advertising segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood
CTChip FR1 biochip that isolate the CTCs from leukocytes, as well as technology development, technology transfer, marketing, sale and distribution of biomedical technology, life and medicine science related products and services, integrated marketing services provider in the gaming industry, multi-channel networking and live-streaming and investment activities.
Formerly known as Biolidics Limited, the company rebranded as Embracing Future Holdings Limited in June 2025. Embracing Future Holdings Limited was incorporated in 2009 and is based in Singapore.